Clinical trial
Companion Pharmacogenetic Study to UMCC 9900/9901
NCT00146029 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00146029 |
|---|---|
| Title | Companion Pharmacogenetic Study to UMCC 9900/9901 |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Metastatic Breast Cancer |
| First posted | Sep 5, 2005 |
| Last update posted | Mar 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: